BMC Medical Imaging · 2020 · 51 citations · 17 references
MedicineOncologySurgeryGastrointestinal OncologyMetastasisOncologic ImagingCancer StagingCancer Survival AnalysisEsophageal CancerEsophageal DiseasesTumor CharacterizationTumor StagingCancer Stage PrognosticationCox RegressionEsophageal Cancer StagingLocal Tumor StagingMetabolic Tumor CharacterizationMetabolic Tumor VolumeTotal Lesion GlycolysisTumor Location Assessment
Abstract Background Although 18 F- FDG PET/CT is validated in baseline workup of esophageal cancer to detect distant metastases, it remains underused in assessing local staging and biology of the primary tumor. This study aimed to evaluate the association between 18 F- FDG PET/CT-derived parameters of esophageal cancer, and its clinico-pathological features and prognosis. Methods All patients ( n = 86) with esophageal adenocarcinoma or squamous cell cancer operated between 2005 and 2014 were analyzed. Linear regression was used to identify clinico-pathologic features of esophageal cancer associated with the tumor’s maximal Standardized Uptake Value (SUV max ), Total Lesion Glycolysis (TLG) and Metabolic Tumor Volume (MTV). ROC curve analysis was performed to precise the optimal cutoff of each variable associated with a locally advanced (cT3/4) status, long-term survival and recurrence. Kaplan Meier curves and Cox regression were used for survival analyses. Results High baseline SUV max was associated with cT3/4 status and middle-third tumor location, TLG with a cT3/4 and cN+ status, whereas MTV only with active smoking. A cT3/4 status was significantly predicted by a SUV max > 8.25 g/mL ( p < 0.001), TLG > 41.7 ( p < 0.001) and MTV > 10.70 cm 3 ( p < 0.01) whereas a SUV max > 12.7 g/mL was associated with an early tumor recurrence and a poor disease-free survival (median 13 versus 56 months, p = 0.030), particularly in squamous cell cancer. Conclusions Baseline 18 F- FDG PET/CT has a high predictive value of preoperative cT stage, as its parameters SUV max , TLG and MTV can predict a locally advanced tumor with high accuracy. A SUV max > 12.7 g/mL may herald early tumor recurrence and poor disease-free survival.
17
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Florian Lordick, C. Mariette, Karin Haustermans et al. · Annals of Oncology · 2016 · 1.1K citations · Full text
Nabil P. Rizk, Robert J. Downey, Timothy Akhurst et al. · The Annals of Thoracic Surgery · 2006 · 120 citations · Full text